Biography of Vikram Karnani

Last update: April 4, 2024

Career

Vikram was Vice President, Therapeutics and Cell Therapy at Fenwal, and Senior Field Applications Engineer at Freescale Semiconductor. Vikram Karnani joined Amgen in 2014. Vikram served as Senior Vice President, Rheumatology Business Unit at Amgen.

Vikram Karnani is currently Executive Vice President and President, Global Commercial Operations and Medical Affairs at Amgen Rare Disease - View - Amgen Rare Disease org chart

Create your alert
to follow the career of Vikram Karnani.

Education

Vikram Karnani has a Master of Science in Electrical Engineering from Case Western Reserve University in 1998 and a Master of Business Administration in General Management And Strategy, Marketing and Finance from Northwestern University - Kellogg School of Management in 2007.

They have also studied at Case Western Reserve University :

Find more alumni from Case Western Reserve University


They have also studied at Northwestern University - Kellogg School of Management :

Find more alumni from Northwestern University - Kellogg School of Management

The colleagues of Vikram Karnani

Company Colleagues
Industry Colleagues
  • In the Pharmaceuticals industry, Vikram Karnani has 19,357 colleagues in 1,860 companies located in 69 countries. 8,443 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.

Report an error
Update the org chart details of Vikram Karnani.

Get in Touch

Use our Premium/VIP Service to contact Vikram Karnani by email now. Here are a few tips for establishing great contacts.

Send an email
to Vikram Karnani.
With Skype, Call Amgen Rare Disease at +1 224... and ask for Vikram Karnani.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.